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ABSTRACT
Aims: Leigh syndrome (LS) is characterised by almost
identical brain changes despite considerable causal
heterogeneity. SURF1 gene mutations are among the
most frequent causes of LS. Although deficiency of
cytochrome c oxidase (COX) is a typical feature of the
muscle in SURF1-deficient LS, other abnormalities have
been rarely described. The aim of the present work is to
assess the skeletal muscle morphology coexisting with
SURF1 mutations from our own research and in the
literature.
Methods: Muscle samples from 21 patients who fulfilled
the criteria of LS and SURF1 mutations (14 homozygotes
and 7 heterozygotes of c.841delCT) were examined by
light and electron microscopy.
Results: Diffuse decreased activity or total deficit of COX
was revealed histochemically in all examined muscles. No
ragged red fibres (RRFs) were seen. Lipid accumulation
and fibre size variability were found in 14 and 9
specimens, respectively. Ultrastructural assessment
showed several mitochondrial abnormalities, lipid depos-
its, myofibrillar disorganisation and other minor changes.
In five cases no ultrastructural changes were found. Apart
from slight correlation between lipid accumulation shown
by histochemical and ultrastructural techniques, no other
correlations were revealed between parameters investi-
gated, especially between severity of morphological
changes and the patient’s age at the biopsy.
Conclusion: Histological and histochemical features of
muscle of genetically homogenous SURF1-deficient LS
were reproducible in detection of COX deficit. Minor
muscle changes were not commonly present. Also,
ultrastructural abnormalities were not a consistent
feature. It should be emphasised that SURF1-deficient
muscle assessed in the light and electron microscopy
panel may be interpreted as normal if COX staining is not
employed.
Leigh syndrome (LS), first described in 1951, is a
severe neurodegenerative disease with characteris-
tic neuropathological lesions located mainly in the
basal ganglia, brain stem and sometimes other
structures of central nervous system.
1 Since the
first description, hundreds of patients with LS-type
brain changes have been reported. Various respira-
tory chain dysfunctions and/or the presence of
different mitochondrial DNA mutations have been
considered characteristic for all LS patients.
2
The SURF1 gene discovered in 1998 is the first
nuclear gene for which the association of its
mutations with deficiency of respiratory chain
complex IV (cytochrome c oxidase (COX)) has
been confirmed in humans.
34 The SURF1 muta-
tions were found invariably and almost exclusively
in patients with generalised COX-deficit coexistent
with LS features. Nearly 60 such patients and over
35 different mutations have been reported so far in
the literature.
5–32 SURF1 encodes for one of several
proteins involved in proper assembly of the active
COX complex.
Despite numerous detailed reports in muscle
pathology in many different mitochondrial dis-
orders
33 34 the character of skeletal muscle lesions in
SURF1-deficient LS has not been precisely
described to date. In order to establish if there are
any lesions of skeletal muscle specific for the
SURF1 gene mutated patients, we summarised
results of muscle biopsy in 21 patients with
confirmed SURF1 gene mutations. Our analysis
also includes data on 15 patients available from the
literature (patients were of English, French and
Czech nationality).
PATIENTS AND METHODS
Retrospective pathological investigations were per-
formed in all children with the diagnosis of LS
established at our mitochondrial centre during the
period 1994–2005 in whom genetic molecular
studies eventually revealed the presence of SURF1
gene mutations.
Skeletal muscle samples from 21 patients from
20 unrelated Polish families (11 boys and 10 girls,
aged from 9 months to 12 years) were reassessed by
light and/or electron microscopy.
Commonly accepted clinical criteria was applied
for establishing the LS diagnosis in the patients.
35
Biochemical assays of muscle homogenates showed
a decrease in activity of complex IV of the
respiratory chain and an increase in activity of
citric synthase (CS). Molecular analysis of the
SURF1 gene revealed the presence of the
c.841delCT (formerly c.845delCT) mutation in all
patients studied. Twelve patients were homozy-
gous for this mutation, and the remaining seven
were compound heterozygous. Clinical, biochem-
ical and molecular characteristics of the patients
are presented in table 1, and were also published in
part previously.
13 27 36 37
Skeletal muscle was obtained by open surgical
biopsy of the vastus lateralis as a diagnostic
procedure. Pathological studies comprised light
microscopic assessment of frozen sections stained
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460 J Clin Pathol 2008;61:460–466. doi:10.1136/jcp.2007.051060Table 1 Clinical and molecular characteristics of 21 Polish Leigh syndrome (LS) patients with SURF1 gene mutations
Patient
no.
Age at diagnosis
(year of birth) Clinical symptoms Brain imaging, autopsy
Complex IV
activity
(% citric
synthase)
Citric synthase activity
(nmol/min/g protein)
Presence of c.841delCT SURF1
mutation at both alleles*/
1 2 years (1987) 4 months: motor regression,
floppiness, bulbar symptoms,
hirsutism, lactic acidaemia
,3.0 70.4 c.841delCT +
2 7 years (1987) 12 months: trembling, uncertain
gait, myoclonic jerks, strabismus
MRI: hyperintensive signals
at lenticular nuclei areas
5.7 146 c.841delCT +
3 12 years (1987) 30 months: dystonic movements,
failure to thrive
MRI: symmetric
hyperintensive signals at
lenticular and caudate nuclei,
medulla oblongata putamen,
globi pallidi
3.5 224.6 c.841delCT +
4 3.5 years (1989) 5 months: failure to thrive,
floppiness, nystagmus, irregular
ventilation, trembling, hirsutism.
LS diagnosed at autopsy of
older brother
9.6 311 c.841delCT c.841delCT
5 4 years (1989) 12 months: failure to thrive,
vomiting, irregular ventilation.
Death at the age of 4
CT: Symmetric hypodensive
changes in basal ganglia
NA NA c.841delCT c.841delCT
6 6.5 years (1990) 16 months: speech difficulties,
hypotonia, nystagmus, motor
regression. LS diagnosed at
autopsy of sibling
(see patient 11)
7.4 86 c.841delCT +
7 3.75 years (1990) 2 years: difficulty in walking and
speaking, failure to thrive,
strabismus, hirsutism,
hyperventilation episodes; CT of
older brother: hypodense areas
at LS typical localisation
8.4 121.7 c.841delCT c.841delCT
8 3 years (1990) 12 months: failure to thrive,
floppiness, hirsutism, irregular
respiration. CT and autopsy of
older sister revealed typical LS
changes
NA NA c.841delCT c.841delCT
9 3 years (1991) 14 months: regression of motor
skills, failure to thrive, hirsutism,
tremor, eye movement
dissociation, apneic bouts,
death at the age of 2.5 years
,3.0 175 c.841delCT c.841delCT
10 2.5 years (1992) 3 months: failure to thrive,
hypotonia, hirsutism; MRI of
younger affected brother: LS
changes in basal ganglia
CT: hypodensic areas in
both cerebellar hemispheres
and caudate nuclei
,3.0 136 c.841delCT c.841delCT
11 10 years (1993) 16 months: nystagmus, speech
and walking difficulties. Died at
age of .10 years
At autopsy: spongiform
lesions; vascular
proliferation and neuronal
loss in mesencephalon,
diencephalon, medulla, and
white matter of cerebellum
,3.0 104.1 c.841delCT +
12 1.75 years (1994) 9 months: hypotonia, floppiness,
failure to thrive, vomiting, tremor
NA NA c.841delCT c.841delCT
13 2 years (1995) 19 months: tremor, eye
movement dissociation,
dystonia, irregular breathing
CT: Symmetric hypodense
areas of basal ganglia
6.2 194.9 c.841delCT c.841delCT
14 3 years (1996) 12 months; floppiness, irregular
respiration, eye movement
dissociation, strabismus,
hirsutism
MRI at 2.5 years: symmetric
hyperintensive signals in
basal ganglia
3.7 111.4 c.841delCT +
15 2.75 years (1997) 4 months: motor regression,
failure to thrive, floppiness,
tremor, hirsutism, lactic
acidaemia
5.3 112.7 c.841delCT c.841delCT
16 9 months (1997) 2 months: floppiness, vomiting,
irregular respiration, eye
dissociation, ptosis, hirsutism.
LS in older brother
MRI at 4 years: symmetric
hyperintensive signals in
basal ganglia, brain atrophy
3.6 223 c.841delCT c.841delCT
17 1.5 years (1997) 7 months; failure to thrive,
vomiting, hypotonia, hirsutism,
strabismus, lactic acidaemia
5.8 174 c.841delCT c.841delCT
Continued
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trichrome, oil red O, succinate dehydrogenase (SDH), COX,
NADH dehydrogenase, acid phosphatase, and myosin ATPase
at pH 4.3, 4.6, and 9.4. Assessment was performed in parallel
with ongoing mitochondrial biochemical and clinical diagnostics.
For ultrastructural study the tissue was fixed in 2.5% cold
glutaraldehyde for 1 h, washed in cacodylate buffer, post-fixed
in 1% osmium tetroxide, dehydrated in graded alcohols and
embedded in Epon 812 resin (DDSA, MNA; Serva, Heidelberg,
Germany). The semi-thin sections were stained with toluidine
blue to identify the region for ultrastructural study. Transverse
and longitudinal sections were examined. Ultra-thin sections
were counterstained with uranyl acetate and lead citrate and
examined in a JEOL 1500 electron microscope (Tokyo, Japan).
All muscle samples were processed for electron microscopy (EM)
in the years 1994–2005.
The study protocol has been accepted by the institutional
Childrens’ Memorial Health Institute Bioethical Commission.
RESULTS
Muscle light microscopy and electron microscopy results
obtained from the individual patients are shown in the table 2.
Histological and histochemical pattern of muscle changes
were similar in all children with SURF1 gene mutations. Diffuse
decreased activity or total deficit of COX activity was found in
all patients (fig 1A,B).
In most children, COX deficit was accompanied by slight to
moderate accumulation of lipids in muscle (fig 1C). Only three
patients demonstrated no lipid increase. Half of the patients
showed mild variability in muscle fibre diameter (fig 1D).
Predominance of type 1 fibres was not found in the muscle with
the exception of three cases. One case showed mild tendency for
fibre type grouping. This phenomenon (not seen in any other
patient) was considered unrelated to the primary molecular
defect. No patient showed presence of RRF or increase of
succinate dehydrogenase activity in muscle.
Ultrastructural examination of skeletal muscles biopsies
revealed a spectrum of morphological abnormalities consisting
mainly of more or less detectablemitochondrial alterations (fig 2).
In a majority of patients (12 of 19 examined cases), several muscle
fibres demonstrated distinct subsarcolemmal accumulation of
altered mitochondria (fig 2B,C). Frequently, the mitochondria
were markedly enlarged or elongated (fig 2C,D) and exhibited
dark matrix with densely packed, concentrically arranged lamellar
cristae (fig 2D,E). Occasionally, the mitochondrial matrix
displaced spaces with amorphous granular material and small,
electron-dense, osmophilic granules (fig 2D). Extensive accumula-
tion of lipid deposits occurred in association with normal and
altered mitochondria (fig 2F,G). Some muscle fibres revealed
alterations of myofibrils including their focal or widespread
disorganisation and/or disruption (fig 2A–H,I). Moreover, the
tubulofilamentous structures typical of cytoplasmic body forma-
tion and subsarcolemmal aggregation of concentric laminated
bodies were also found in individual cases (fig 2H).
Major changes in mitochondria on electron microscopy were
not common in all SURF1-deficient LS patients, and were
observed in a third of the cases (fig 3). The picture was normal
in five cases and mild in two others.
No correlation was found between the electron microscopy
findings and the light microscopy findings (ie, variability of fibre
size), or with the clinical parameters (ie, age of biopsy and
homozygous/heterozygous status of c.841delCT mutation).
A slightly significant correlation was found only between
presence of lipid accumulation demonstrated by light and
electron microscopy (Pearson test 0.39; p,0.05).
DISCUSSION
SURF1-deficient LS presents a special sub-group of LS in which
an as-yet unexplained homogeneity of changes in the brain
36 37
Table 1 Continued
Patient
no.
Age at diagnosis
(year of birth) Clinical symptoms Brain imaging, autopsy
Complex IV
activity
(% citric
synthase)
Citric synthase activity
(nmol/min/g protein)
Presence of c.841delCT SURF1
mutation at both alleles*/
18 1.5 years (1998) 14 months: motor regression,
trembling, hirsutism, hypotonia
MRI: symmetric
hyperintensive signals in
basal ganglia
4.3 133.2 c.841delCT c.841delCT
19 1.5 years (2000) 7 months: motor regression,
irregular respiration, vomiting
MRI: symmetric
hyperintensive signals in
basal ganglia
,3.0 296.6 c.841delCT c.841delCT
20 1 year (2000) In infancy: failure to thrive,
vomiting, tremor, irregular
ventilation, lactic acidaemia.
Prolonged artificial ventilation
before death
Autopsy at 4 years:
Massive encephalomalacia
obscurring topography of
possible lesions. Severe
mixed liver steatosis (90%);
numerous lipid vacuoles in
proximal convoloted renal
tubules
,3.0 104.1 c.841delCT +
21 1.5 years (2002) 6 months: failure to thrive,
hypotonia, hyperventilation
episodes, lactic acidaemia
MRI: symmetric hyperintensive
signals at lenticular nuclei,
putamen, crura cerebri,
substantia
nigra, cerebellum periventricular
areas,
medulla oblongata.
,3.0 209.7 c.841delCT c.841delCT
Average
(mean (SD))
4.7 (2.1) 175.7 (38.2)
Reference
(18 cases;
mean (SD))
26.4 (7.4) 123.0 (26.0)
CT, computer tomography; MRI, magnetic resonance imaging; NA, not analysed; +, presence of non-c.841delCT mutations.
13 27 36
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ground. The exact role of the SURF1 protein has not been fully
elucidated, but it is well known that without its contribution
the COX complex is assembled improperly and functionally
impaired.
38–41 SURF1 acts in the early steps of COX assembly
and may promote the association of the mitochondrially-encoded
subunit COXII with the COXI–COXIV–COXV subassembly.
There is a paucity of data on the typical morphological features of
skeletal muscle in SURF1-deficient LS patients. In the majority of
publications referring to SURF1 gene mutations, skeletal muscle
morphology is not included or it is limited to histochemical
confirmation of COX deficit.
51 21 61 92 12 2 – 2 42 62 8 Only anecdotal
Figure 1 Histochemical and histological
findings in the muscle of patients with
Leigh syndrome associated with c.
841delCT SURF1 gene mutation. A. Total
diffuse cytochrome c oxidase (COX)
deficit. B. Reference positive COX
reaction (patient with encephalopathy of
unknown cause examined in the same
batch). C. Moderate lipid increase in
muscle fibres. D. Variability of muscle
fibre diameter.
Table 2 Histological, histochemical and electron microscopy findings in skeletal muscle of 21 children with Leigh syndrome (LS) and SURF1 gene
mutation
Patient
no.
Age at
biopsy
(years)
COX
deficiency RRF
Lipid
accumulation
Other pathology of skeletal
muscle fibres
Abnormal
MT*
Lipid
droplets
Miofibrile
loss
Cytoplasmic
bodies
Concentric
laminated
bodies
12 ++ 2 + Variability of diameter + 22 2 2
27 ++ 2 ++ Not found +/2 ++ 22
31 2 ++ 2 ++ Mild variability of diameter 2 ++ 22
4 3.5 NA 2 NA Not found + 2 + 22
54 N A2 + Not found 22 + 22
6 6.5 ++ 22 Variability of diameter ++ 22 + 2
7 3.75 ++ 2 + Not found 2 + 22 2
83 N A22 Not found NA NA NA NA NA
93 + 2 ++ Not found + 22 2 2
10 2.5 ++ 2 + Mild variability of diameter ++ + + 2 +
11 10 ++ 2 + Variability diameter, fibre type
grouping
2 + 22 2
12 1.75 + 2 + Not found +/2 ++ 22
13 2 ++ 2 ++ Predominance of type I fibres ++ + 22 2
14 3 ++ 22 Mild interstitial fibrosis ++ 22 2
15 2.75 ++ 2 + Predominance of type I fibres 22 + 22
16 0.75 ++ 2 + Predominance of type I fibres ++ + 22 2
17 1.5 + 2 ++ Variability of diameter + 2 + 22
18 1.5 + 2 ++ Not found ++ 22 2
19 1.5 + 2 ++ Mild variability of diameter 2 + 22 2
20 1 ++ 22 Mild variability of diameter 22 22 2
21 1.5 + 2 ++ Mild variability of diameter NA NA NA NA NA
Light microscopy and electron microscope findings: +/2 mild changes; + moderate changes; ++ severe changes; 2 no changes; *Mitochondrial (MT) ultrastructure abnormalities:
+++: increase in mitochondrial number, changes in size, shape, and presence of electron dense inclusions; ++: increase in mitochondrial number, variation in size and shape; +:
increase in mitochondrial number, slight variation in size and shape; +/2: slight increase in mitochondrial number.
COX, cytochrome c oxidase; NA, not analysed; RRF, ragged red fibre.
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reports are available (table 3).
The experimental model of SURF1-deficient mice presented
with profound and isolated defect of COX activity, reduced
histochemical reaction of COX, and mitochondrial prolifera-
tion.
47
The cohort reported in this study was especially homogenous,
carring the same c.841delCT mutation on both or one of alleles
of the SURF1 gene. This mutation is frequent among Polish,
Czech and probably other Slavonic populations.
13 15 17 27 28 36
Here, we demonstrate that muscle biopsy of patients carrying
the c.841delCT SURF1 gene mutation show features that are
similar to those found in the knock-out mice.
47 In a manner akin
to the results observed in the mouse model, all but two patients
did not show a predominance of type I fibres (table 2). This is in
agreement with the findings previously reported for cases with
SURF1 gene mutations (table 3). By contrast, this finding is
considered frequent in the mitochondrial myopathies in
general.
48
Among other minor features of the mitochondrial lesions lipid
accumulation was seen more frequently in our material, and
was present in 14 examined SURF1-LS specimens (table 2).
Similarly the lipid accumulation was also commonly found in
the SURF1-deficient LS muscles described earlier (table 3). The
next quite frequent feature found in the studied material was
variability of fibre size, present in nine muscle samples. Some
degree of this abnormality was also mentioned in the previously
reported cases (table 3). In general, the muscle morphology of
these patients does not differ significantly from our findings.
The so-called ‘‘Polish’’ SURF1 mutation of c.841delCT, the most
prevalent in our patients, was not found in any of the described
cases.
It is important to emphasise that the presence of RRFs in the
muscle, characteristic of mtDNA encoded mitochondrial myo-
pathies, was extremely rare if not non-existent in the nuclearly
encoded SURF1-LS muscle specimens, particularly in those
carrying c.841delCT mutations. There is only one description of
LS with SURF1 mutations showing RRFs in a patient carrying
two protein truncated mutations (table 3).
25 RRFs were also not
detected in the muscle of SURF1-deficient knock-out mice.
47
However, the signs of increased mitochondria number seem
not to be rare in the SURF1-deficient muscle. Subsarcolemmal
NADH–tetrazolium positive rims,
42 or intense subsarcolemmal
SDH staining
45 suggested incipient mitochondrial proliferation.
Increased SDH reaction was also seen in the animal knock-out
model of the disease.
47 These reactions were negative in all our
muscle specimens with homozygous and heterozygous
c.841delCT SURF1 gene mutation.
Ultrastructural assessment of knock-out mice revealed
marked subsarcolemmal accumulation of enlarged mitochon-
dria. Our ultrastructural findings in the affected human muscles
Figure 2 Ultastructural findings in the
muscle of patients with Leigh syndrome
associated with c. 841delCT SURF1 gene
mutation. In a majority of patients (12 of
19 examined cases), several muscle
fibres demonstrated distinct
subsarcolemmal accumulation of altered
mitochondria (B, C). Frequently, the
mitochondria were markedly enlarged or
elongated (C, D) and exhibited dark matrix
with densely packed, concentrically
arranged lamellal cristae (D, E).
Occasionally, the mitochondrial matrix
displaced spaces with amorphous
granular material and small, electron-
dense, osmophilic granules (D). Extensive
accumulation of lipid deposits occurred in
association with normal and altered
mitochondria (F, G). Some muscle fibres
revealed alterations of myofibrils
including their focal or widespread
disorganisation and/or disruption (A, H, I).
Moreover, the tubulofilamentous
structures typical of cytoplasmic body
formation and subsarcolemmal
aggregation of concentric laminated
bodies were also found in individual cases
(H). Original magnification: A, 612 000;
B, C, F, 67500; D, G, 615 000; E,
610 000; H, 620 000; I, 63000.
Figure 3 Distribution and frequency of various ultrastructural changes
among 21 muscles of patients with SURF1-deficient Leigh syndrome.
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increased number of mitochondria in several cases, but not in all
of them. In the literature there is only scant information on the
ultrastructure of human SURF1-deficient LS muscles. An
exception is one case with COX-deficient Leigh syndrome
reported in 1977.
49 Thirty years later, a homozygous c.370C.A
SURF1 gene mutation was identified in this patient.
50 The
dominant ultrastructural feature of this case was enlarged
mitochondria of bizarre shape and various size and form,
aggregated in juxtanuclear and subsarcolemmal regions. The
mitochondria contained an excessive number of irregularly
arranged and distorted cristae. Fine granular electron-dense
material was seen in the matrix, but paracristalline inclusions
and large spherical dense bodies were absent. Myofibrils and
myofilaments were preserved. Lipid droplets were seen in
association with abnormal mitochondria.
49
In agreement with this description, our ultrastructural study
confirms that SURF1 mutations may be associated with
detectable structural manifestations of mitochondrial involve-
ment. However, approximately a third of our SURF1-deficient
muscle specimens (and the remaining two reports of ultra-
structural findings in the literature)
78did not demonstrate any
ultrastructural anomalies of the mitochondria.
Ultrastructural abnormalities found by us were similar to
these seen in the animal model of the disease.
47 However it is
not possible to identify any morphological or ultrastructural
features that are exclusively and commonly present in muscles
with SURF1 mutations. Our results and those described in the
literature data indicate that mitochondrial abnormalities can
not be considered specific for the SURF1-deficient LS as it is
unanimously accepted for all mitochondrial disorders, including
those associated with mtDNA mutations.
On the basis of our study we propose that a diffuse deficit of
COX in the muscle by histochemical staining, in particular in a
child of Polish origin with a clinical phenotype of LS, should
prompt direct molecular testing for the c.841delCT mutation in
the SURF1 gene. In our experience the contribition of an
experienced clinical pathologist was very useful at this step of
diagnosis of mitochondrial disorders in children.
51 Additional
histological features such as lack of RRFs and normal fibre size
proportion, presence of lipid accumulation of mild to remark-
able degree and fibre size variability had only limited diagnostic
value in differential diagnosis of LS associated with SURF1 gene
mutations.
The electron microscopy showed no abnormalities in a third
of our SURF1-deficient muscle biopsies, as in three of four
descriptions found in the literature.
784 6This demonstrates that
the diagnostic value of minor ultrastructural abnormalities is
disputable, especially in children with a suspicion of mitochon-
drial disorder.
52 53
In conclusion, diffuse COX deficit in muscle biopsies is
the only reproducible pathological finding of patients with
LS. It should be emphasised that samples from LS patients
solely assessed by means of microscopy or by histochemistry
using a panel not including COX may be misinterpreted as
normal.
Acknowledgements: The authors thank Professor Ewa Pronicka for inspiration and
critical remarks.
Funding: This work was supported by MitoNet, the Polish Mitochondrial Network
(http://mitonet.pl).
Competing interests: None declared.
Table 3 Muscle histology and histochemistry of patients with SURF1 gene mutation found in published case reports
Muscle histology and histochemistry Age at biopsy SURF1 mutations References
COX deficit, remarkable lipid accumulation; subsarcolemmal increase
of NADH activity
5 years A patient from Tirani’s SURF1-deficient
complementary group with ‘‘atypical’’ LS
Tiranti et al,
3 Tirani et al,
43
Angelini et al
42 and Munaro et
al
44
COX partial deficit, slight subsarcolemmal increase of SDH activity Not reported c.312del10insAT//c.567insCAGG Sue et al
9 and Van Coster et al
45
Normal findings 1.5 years c.589insCTGC//c.702C.T Poyau et al
8 and Collombet et
al
46
COX deficit, subsarcolemmal increase of SDH and NADH activity 4 years c.312del10insAT//c.385G.A Poyau et al
8 and Collombet et
al
46
Normal findings (COX not assessed) 3 years c.312del10insAT//c.385G.A Poyau et al
8 and Collombet et
al
46
Variability in fibre size 1.5 years c.790delAG//c.820T.G Teraoka et al
7
COX deficit, lipid accumulation 2 years c.240+1G.T// c.531_534delAAAT Bruno et al
18
COX deficit slight variability of fibre diameter, several hypotrophic fibres 5 years Homozygous Q82X Santoro et al
10
Lipid accumulation, atrophy of type II fibres 2.5 years Homozygous c.790_791delAG Rahman et al
14
COX deficit ,2 years c.312del10insAT//c.688C.T Tay et al
25
COX deficit, type I fibres atrophy ,2 years Homozygous c.834G.A Tay et al
25
COX deficit, mild non-specific changes ,2 years As above (siblings) Tay et al
25
COX deficit; several RRFs ,2 years c.312del10insAT//c 822_824dupTACAT Tay et al
25
COX deficit Not done c.608T.C//c.675_692del18 Sacconi et al
20
Normal findings (including COX staining)* 3 years Homozygous c.867G.A Van Riesen et al
29
*Severe isolated COX deficiency detected by biochemical assay.
COX, cytochrome c oxidase; LS, Leigh syndrome; RRF, ragged red fibre; SDH, succinate dehydrogenase.
Take-home messages
c SURF1-deficient skeletal muscle of patients with Leigh
syndrome (LS) shows a reproducible and characteristic
pattern of changes in light and electron microscopy that are
potentially helpful in diagnosis.
c It should be kept in mind that those changes are not specific.
c Diffuse cytochrome c oxidase (COX) deficit remains the salient
feature, and muscle may be interpreted as normal if the
histochemical panel does not include COX reaction. The role of
an experienced pathologist at this step of LS investigation is
therefore important.
Original article
J Clin Pathol 2008;61:460–466. doi:10.1136/jcp.2007.051060 465REFERENCES
1. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg
Psychiat 1951;14:216–21.
2. Di Donato S. Disorders related to mitochondrial membranes: pathology of the
respiratory chain and neurodegeneration. J Inherit Metab Dis 2000;23:247–63.
3. TirantiV,HoertnagelK,CarrozoR,etal.MutationsofSURF-1inLeighdiseaseassociated
with cytochrome c oxidase deficiency. Am J Hum Genet 1998;63:1609–21.
4. Zhu Z, Yao J, Johns T, et al. SURF1, encoding a factor involved in the biogenesis of
cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998;20:337–43.
5. Tirani V, Jaksch M, Hofmann S, et al. Loss-of-function mutations of SURF-1 are
specifically associated with Leigh syndrome with cytochrome c oxidase deficiency.
Ann Neurol 1999;46:161–6.
6. Coenen MJH, van den Heuvel LP, Nijtmans LGJ, et al. SURFEIT-1 gene analysis and
two-dimensional blue native gel electrophoresis in cytochrome c oxidase deficiency.
Bioch Biophys Res Commun 1999;265:339–44.
7. Teraoka M, Yokoyama Y, Ninomiya S, et al. Two novel mutations of SURF1 in Leigh
syndrome with cytochrome c oxidase deficiency. Hum Genet 1999;105:560–3.
8. Poyau A, Bucht K, Bouzidi MF, et al. Missense mutations in SURF1 associated with
deficient cytochrome c oxidase assambly in Leigh syndrome patients. Hum Genet
2000;106:194–205.
9. Sue CM, Karadimas C, Checcarelli N, et al. Differential features of patients with
mutations in two COX assembly genes, SURF-1 and SCO2. Ann Neurol 2000;47:589–95.
10. Santoro L, Carrozzo R, Malandrini A, et al. A novel SURF1 mutation results in Leigh
syndrome with peripheral neuropathy caused by cytochrome c oxidase deficiency.
Neuromuscular Dis 2000;10:450–3.
11. Pequignot MO, Dey R, Zeviani M, et al. Mutations in the SURF1 gene associated
with Leigh syndrome and cytochrome c oxidase deficiency. Hum Mut 2001;17:375–
81.
12. Pequignot MO, Desguerre I, Dey R, et al. New splicing-site mutations in the SURF1
gene in Leigh syndrome. J Biol Chem 2001;276:15326–9.
13. Piekutowska-Abramczuk D, Popowska E, Pronicka E, et al. SURF1 gene mutations
in Polish patients with COX-deficient Leigh syndrome. J Appl Genet 2001;42:103–8.
14. Rahman S, Brown RM, Chong WK, et al. A SURF1 gene mutation presenting as
isolated leukodystrophy. Ann Neurol 2001;49:797–800.
15. Williams SL, Taanman J-W, Hansikova H, et al. A novel mutation in SURF1 causes
skipping of exon 8 in a patient with cytochrome c oxidase-deficient Leigh syndrome
and hypertrichosis. Mol Genet Metab 2001;73:340–3.
16. Von Kleist-Retzow J-Ch, Yao J, Taanman J-W, et al. Mutations in SURF1 are not
specifically associated with Leigh syndrome. J Med Genet 2001;38:109–13.
17. Capkova M, Hansikova H, Godinot C, et al. A new missense mutation of574C.Ti n
the SURF1 gene – biochemical and molecular genetic study in seven children with
Leigh syndrome (in Czech). Cas Lek Cesk 2002;141:636–41.
18. Bruno C, Biancheri R, Garavaglia B, et al. A novel mutation in the SURF1 gene in a
child with Leigh disease, peripheral neuropathy, and cytochrome-c oxidase deficiency.
J Child Neurol 2002;17:233–6.
19. Ogawa Y, Naito E, Ito M, et al. Three novel SURF-1 mutations in Japanese patients
with Leigh syndrome. Pediatr Neurol 2002;26:196–200.
20. Sacconi S, Salviati L, Sue CM, et al. Mutation screening in patients with isolated
cytochrome c oxidase deficiency. Ped Res 2003;53:224–30.
21. Rossi A, Biancheri R, Bruno C, et al. Leigh syndrome with COX deficiency and SURF1
gene mutations: MR imaging findings. Am J Neuroradiol 2003;24:1188–91.
22. Moslemi A-R, Tulinius M, Darin N, et al. SURF1 gene mutations in three cases with
Leigh syndrome and cytochrome c oxidase deficiency. Neurology 2003;61:991–3.
23. Head RA, Brown RB, Brown GK. Diagnostic difficulties with common SURF1
mutations in patients with cytochrome oxidase-deficient Leigh syndrome. J Inherit
Metab Dis 2004;27:57–65.
24. Salviati L, Freehauf C, Sacconi S, et al. Novel SURF1 mutation in a child with
subacute encephalopathy and without the radiological features of Leigh syndrome.
Am J Med Genet 2004;128A:195–8.
25. Tay SK, Sacconi S, Akman HO, et al. Unusual clinical presentations in four cases of
Leigh disease, cytochrome oxidase deficiency, and SURF1 gene mutations. J Child
Neurol 2005;20:670–4.
26. Monnot S, Chabrol B, Cano A, et al. Syndrome de Leigh avec deficit en cytochrome
c oxidase lie a une mutation homozygote du gene SURF1 (in French). Arch Pediat
2005;12:568–71.
27. Bohm M, Pronicka E, Karczmarewicz E, et al. Retrospective, multicentric study of
180 children with cytochrome c oxidase deficiency. Ped Res 2006;59:21–6.
28. Ostergaard E, Bradinova I, Ravn SH, et al. Hypertrichosis in patients with SURF1
mutations. Am J Med Genet 2005;138A:384–8.
29. Van Riesen AKJ, Antonicka H, Ohlenbusch A, et al. Maternal segmental disomy in
Leigh syndrome with cytochrome c oxidase deficiency caused by homozygous SURF1
mutation. Neuropediatrics 2006;37:88–94.
30. Coenen MJH, Smeitink JAM, Pots JM, et al. Sequence analysis of the structural
nuclear encoded subunits and assembly genes of cytochrome c oxidase in a cohort of
10 isolated complex IV-deficient patients revealed five mutations. J Child Neurol
2006;21:508–11.
31. Yang Y-l, Sun F, Zhang Y, et al. Clinical and laboratory survey of 65 Chinese patients
with Leigh syndrome. Chinese Medical Journal 2006;119:373–7.
32. Yuksel A, Seven M, Cetincelik U, et al. Facial dysmorphism in Leigh syndrome with
SURF-1 mutation and COX deficiency. Pediatr Neurol 2006;34:486–9.
33. Bourgeois J, Tarnopolski M. Pathology of skeletal muscle in mitochondrial disorder.
Mitochondrion 2004;4:441–52.
34. DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update. Neuromuscul
Disord 2005;15:276–86.
35. Rahman S, Blok R, Dahl H-H, et al. Leigh syndrome: clinical features and biochemical
and DNA abnormalities. Ann Neurol 1996;39:343–51.
36. Pronicka E, Piekutowska-Abramczuk DH, Popowska E, et al. Compulsory
hyperventilation and hypocapnia of patients with Surf-1 gene mutations as a cause of
low serum bicarbonates. J Inherit Metab Dis 2001;24:717–14.
37. Pronicka E, Halikowski B. Metabolic acidosis versus a compensation of respiratory
alkalosis in four children with Leigh disease. J Inherit Metab Dis 1984;7(Suppl
2):113–4.
38. Pecina P, Capkova M, Chowdhury SKR, et al. Functional alteration of cytochrome
c oxidase by SURF1 mutations in Leigh syndrome. Bioch Biophys Acta
2003;1639:53–63.
39. Wasniewska M, Karczmarewicz E, Pronicki M, et al. Abnormal calcium homeostasis
in fibroblasts from patients with Leigh disease. Biochem Biophys Res Commun
2001;283:687–93.
40. Pecina P, Houstkova H, Hansikova H, et al. Genetic defects of cytochrome c oxidase
assembly. Physiol Res 2004;53(Suppl 1):S213–23.
41. Pecina P, Gnaiger E, Zeman J, et al. Decreased affinity for oxygen of xytochrome c
oxidase in Leigh syndrome caused by SURF1 mutations. Am J Physiol Cell Physiol
2004;287:C1384–8.
42. Angelini C, Bresolin N, Pergolo G, et al. Childhood encephalomyopathy with
cytochrome c oxidase deficiency, ataxia, muscle wasting, and mental retardation.
Neurology 1986;36:1048–52.
43. Tirani V, Munaro M, Sandona D, et al. Nuclear DNA origin of cytochrome c oxidase
deficiency in Leigh’s syndrome: genetic evidence based on patient’s-derived rho
o
transformants. Hum Mol Genet 1995;4:2017–23.
44. Munaro M, Tirani V, Sandona D, et al. A single cell complementation class in
common to several casus of cytochrome c oxidase defective Leigh’s syndrome. Hum
Mol Genet 1997;6:221–8.
45. Van Coster R, Lombes A, De Vivo, et al. Cytochrome c oxidase-associated Leigh
syndrome: phenotypic features and pathogenetic speculations. J Neurosci
1991;104:97–111.
46. Collombet JM, Zabot MT, Vidailhet M, et al. Interet des fibroblasts cutanes en
culture pour le diagnostic des cytopathies mitochondriales. A propos de cinq
observations de deficit en cytochrome oxidase (in French). Pediatrie 1993;48:287–
95.
47. Agostino A, Invernizzi F, Tiveron C, et al. Constitutive knockout of Surf1 is associated
with high embryonic lethality, mitochondrial disease and cytochrome c oxidase
deficiency in mice. Hum Mol Genet 2003;12:399–413.
48. Enns G, Hoppel C, Dearmond S, et al. Relationship of primary mitochondrial
respiratory chain dysfunction to fiber type abnormal in skeletal muscle. Clin Genet
2005;68:337–48.
49. Willems JL, Monnens LAH, Trijbels JMF, et al. Leigh’s encephalopathy in a patients
with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 1977;60:850–7.
50. Coenen MJH, Smeitink JAM, Farhoud MH, et al. The first patient diagnosed with
cytochrome c oxidase deficient Leigh syndrome: progress report. J Inherit Metab Dis
2006;29:213–13.
51. Vogel H. Mitochondrial myopathy and the role of the pathologist in the molecular era.
J Neuropathol Exp Neurol 2001;60:217–27.
52. Miles L, Wong BL, Dinopoulos A, et al. Investigation of children for
mitochondriopathy confirms need for strict patient selection, improved morphological
criteria, and better laboratory methods. Hum Pathol 2006;37:173–84.
53. Uusimaa J, Remes AM, Rantala H, et al. Childhood encephalopathies and
myopathies: a prospective study in a defined population to assess the frequency of
mitochondrial disorders. Pediatrics 2000;105:598–603.
Original article
466 J Clin Pathol 2008;61:460–466. doi:10.1136/jcp.2007.051060